GSK-4418959

N/A

Report date: 2025/02/28 14:32:31
NME

Base Information

Drug NameGSK-4418959
Drug Alias NameGSK4418959GSK-4418959IDE-275GSK-959
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBifunctional 3'-5' exonuclease/ATP-dependent helicase WRN inhibitors
TargetsBifunctional 3'-5' exonuclease/ATP-dependent helicase WRN
Therapy Area/IndicationsSolid tumoursEndometrial NeoplasmsRectal Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesNetherlands +[7] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesIdeaya Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline PlcIdeaya Biosciences Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursEndometrial NeoplasmsRectal Neoplasms +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A